Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide … S Ozturk, K Turgutalp, M Arici, AR Odabas, MR Altiparmak, Z Aydin, ... Nephrology Dialysis Transplantation 35 (12), 2083-2095, 2020 | 214 | 2020 |
Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19 K Turgutalp, S Ozturk, M Arici, N Eren, N Gorgulu, M Islam, S Uzun, ... BMC nephrology 22, 1-10, 2021 | 84 | 2021 |
The impact of membrane permeability and dialysate purity on cardiovascular outcomes G Asci, H Töz, M Ozkahya, S Duman, MS Demirci, M Cirit, S Sipahi, ... Journal of the American Society of Nephrology 24 (6), 1014-1023, 2013 | 64 | 2013 |
The effect of oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine on wound healing: a retrospective analysis of diabetic … S Sipahi, O Gungor, M Gunduz, M Cilci, MC Demirci, A Tamer BMC nephrology 14, 1-6, 2013 | 60 | 2013 |
Epidemiology and determinants of pruritus in pre-dialysis chronic kidney disease patients B Solak, SB Acikgoz, S Sipahi, T Erdem International urology and nephrology 48, 585-591, 2016 | 54 | 2016 |
Predicting the outcome of COVID-19 infection in kidney transplant recipients OA Oto, S Ozturk, K Turgutalp, M Arici, N Alpay, O Merhametsiz, S Sipahi, ... BMC nephrology 22, 1-16, 2021 | 48 | 2021 |
Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model. S Duman, D Bozkurt, S Sipahi, M Sezak, S Ozkan, M Ertilav, S Sen, E Ok Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 24, 104-110, 2008 | 44 | 2008 |
Does immunosuppressive treatment ameliorate morphology changes in encapsulating peritoneal sclerosis? D Bozkurt, S Sipahi, P Cetin, E Hur, Ö Özdemir, M Ertilav, S Sen, ... Peritoneal dialysis international 29 (2_suppl), 206-210, 2009 | 43 | 2009 |
Body composition monitor measurement technique for the detection of volume status in peritoneal dialysis patients: the effect of abdominal fullness S Sipahi, E Hur, S Demirtas, I Kocayigit, D Bozkurt, A Tamer, H Gunduz, ... International urology and nephrology 43, 1195-1199, 2011 | 41 | 2011 |
The effects of renin–angiotensin system inhibition on regression of encapsulating peritoneal sclerosis D Bozkurt, P Cetin, S Sipahi, E Hur, H Nar, M Ertilav, M Sezak, S Duman Peritoneal Dialysis International 28 (5_suppl), 38-42, 2008 | 40 | 2008 |
The association of vitamin D status and vitamin D replacement therapy with glycemic control, serum uric acid levels, and microalbuminuria in patients with type 2 diabetes and … S Sipahi, SB Acikgoz, AB Genc, M Yildirim, Y Solak, A Tamer Medical principles and practice 26 (2), 146-151, 2017 | 35 | 2017 |
What does peritoneal thickness in peritoneal dialysis patients tell us S Duman, SS Ozbek, ES Gunay, D Bozkurt, G Asci, S Sipahi, F Kirçelli, ... Adv Perit Dial 23, 28-33, 2007 | 29 | 2007 |
Impedance ratio: a novel marker and a powerful predictor of mortality in hemodialysis patients C Demirci, G Aşcı, MS Demirci, M Özkahya, H Töz, S Duman, S Sipahi, ... International urology and nephrology 48, 1155-1162, 2016 | 28 | 2016 |
The effects of colchicine on the progression and regression of encapsulating peritoneal sclerosis D Bozkurt, S Bicak, S Sipahi, H Taskin, E Hur, M Ertilav, S Şen, S Duman Peritoneal Dialysis International 28 (5_suppl), 53-57, 2008 | 26 | 2008 |
Epidemiological features of primary glomerular disease in Turkey: a multicenter study by the Turkish Society of Nephrology Glomerular Diseases Working Group A Turkmen, A Sumnu, E Cebeci, H Yazici, N Eren, N Seyahi, K Dilek, ... BMC nephrology 21, 1-11, 2020 | 25 | 2020 |
Agreement of serum potassium measured by blood gas and biochemistry analyzer in patients with moderate to severe hyperkalemia SB Acikgoz, AB Genc, S Sipahi, M Yildirim, B Cinemre, A Tamer, Y Solak The American journal of emergency medicine 34 (5), 794-797, 2016 | 21 | 2016 |
Adult native renal biopsy experience of Ege University for 12 consecutive years E Hur, H Taskin, D Bozkurt, B Sarsik, S Sen, M Ertilav, S Sipahi, A Basci, ... BANTAO Journal 8 (1), 22-29, 2010 | 21 | 2010 |
Fabry disease prevalence in renal replacement therapy in Turkey SF Yalın, N Eren, A Sinangil, VT Yilmaz, E Tatar, AR Ucar, M Sevinc, ... Nephron 142 (1), 26-33, 2019 | 20 | 2019 |
Evaluation of nutritional status with different methods in geriatric hemodialysis patients: impact of gender T Kaya, S Sipahi, C Karacaer, A Nalbant, C Varım, H Cinemre, A Tamer International urology and nephrology 46, 2385-2391, 2014 | 19 | 2014 |
Cutaneuos findings in patients with predialysis chronic kidney disease B Solak, SB Acikgoz, S Sipahi, T Erdem Journal of the European Academy of Dermatology and Venereology 30 (9), 1609-1613, 2016 | 18 | 2016 |